Synerkine Pharma
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.
Total raised
€12M
€12,100,000
Funding rounds
3
Investors
5
distinct backers
Active since
2018-12
latest 2023-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 8y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-13 | Series A | €5.3M | Flerie Invest,InnovationQuarter Capital,Thuja Capital,Utrecht Health Seed Fund | View deal → |
| 2021-12-17 | Series A | €3.5M | Flerie Invest,Thuja Capital,Utrecht Holdings | View deal → |
| 2019-01-01 | Series A | €3.3M | Thuja Capital | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech